Michael Bogart is a Respiratory physician affiliated with Gilead Sciences. OpenAlex indexes 98 publications with 660 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1200 E Ridgewood Ave Ste 303
Ridgewood, NJ 074503937
Telephone
201-689-7755Provider last certified this registry record 6 Aug 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
78.2%beta2-Adrenergic Agonist47.2%Albuterol Sulfate Hfa100%Part D≥30 patientsCorticosteroid23.2%Breo Ellipta64%Symbicort36%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
12.7%Corticosteroid12.7%Prednisone100%Part D≥15 patientsAnti-infectives
9.2%Macrolide Antimicrobial9.2%Azithromycin100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost
BMJ Open Respiratory Research
2024 - Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy
International Journal of COPD
2024 - Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
Journal of Asthma and Allergy
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John McHutchison, MD
Gilead Sciences
Jared Baeten, MD
Gilead Sciences
Joel Gallant, MD, MPH
Gilead Sciences
Wendy Verret
Gilead Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”